Use of newly named drug leads to stable motor symptoms in Parkinson’s
Gain Therapeutics’ oral therapy candidate rexaceract, formerly called GT-02287, stabilized motor symptoms in a small group of people with Parkinson’s disease who were treated for one year. That’s…